Jynneos vaccine effectiveness

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
• Description:
  Updated May 18, 2023
  
  JYNNEOS vaccine is effective at reducing the risk of mpox, with two doses providing the best protection.
  
  Vaccine effectiveness (VE) measures how well vaccination works under real-world conditions to protect people against infection, symptomatic illness, hospitalization, and death. For instance, 70% VE means that the number of vaccinated people who are ill is 70% lower than the number of unvaccinated people who are ill.
  
  Multiple studies are needed to generate reliable, real-world VE estimates. These studies show JYNNEOS can reduce the risk of mpox illness, with two doses providing the best protection. No vaccine is 100% effective. People who have been vaccinated can still get mpox, but vaccination may make illness less severe.
  
  
• Subjects:
  Mpox (monkeypox)/prevention & Control Smallpox Vaccine Vaccination Vaccine Efficacy
• Document Type:
  Webpage
• Name as Subject:
  JYNNEOS® ; JYNNEOS®
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:7b65a7ac849e895614dd97067b7baa9855d688dd9b8b8226ab2e42b4d5320f5d
• Download URL:
  https://stacks.cdc.gov/view/cdc/128711/cdc_128711_DS1.pdf
• File Type:
  [PDF - 199.42 KB ]